ORPHA:91492
Early onset non-syndromic cataract
Publications
12,211
Trials
0
Interventional, condition-specific
Researchers
0
Distinct authors in sample
Gene link
BFSP2, CRYBB3, EPHA2
Moderate
Readiness
5/6
Stages with a signal
Clinical definition (Orphanet)
A rare, genetic, non-syndromic developmental defect of the eye disorder, with high clinical and genetic heterogeneity, most frequently characterized by bilateral, symmetrical, non- cataracts which present at birth or in early-childhood. Additional ocular manifestations (e.g. anterior segment dysgenesis, colobomas, nystagmus, microcornea, microphthalmia, myopia) may be associated, however other organs/systems are usually not affected.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0011060
- OMIM:601371
- UMLS:C1832423
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
5/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedPresent
Moderate — BFSP2, CRYBB3, EPHA2
- LiteraturePresent
12,211 matched papers (8,271 in last 10 years) Source
- Phenotype characterisedPresent
119 HPO annotations (e.g. Progressive visual loss; Nuclear cataract; Sutural cataract) Source
- Animal modelPresent
32 genotype models (Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 1246 for broader category cataract
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Probably — there is moderate evidence for BFSP2, CRYBB3, EPHA2.
GenCC classification: Moderate.
Phenotypes (Monarch / HPO)
119
Associated phenotypes · MONDO:0011060
- Progressive visual loss
- Nuclear cataract
- Sutural cataract
- Microcornea
- Amblyopia
Showing 5 of 119 — open Monarch for the full list.
Animal models (Monarch / Alliance)
32
Model associations linked to this Mondo ID
- CrygsOpj/Crygs+ [background:] involves: 102 * C3H/He * T STOCK·MGI:3584120·Mus musculus
- MipCat-Fr/MipCat-Fr [background:] involves: A/J·MGI:2175110·Mus musculus
- CrygbNop/CrygbNop [background:] Not Specified·MGI:2175806·Mus musculus
- Lim2To3/Lim2To3 [background:] involves: 102 * C3H/He * T STOCK·MGI:2175102·Mus musculus
- MipHfi/Mip+ [background:] involves: 101 * C3H·MGI:2175115·Mus musculus
- CrygsOpj/CrygsOpj [background:] involves: 102 * C3H/He * T STOCK·MGI:3584122·Mus musculus
- CrygbClapper/Crygb+ [background:] C57BL/6J-CrygbClapper·MGI:3603148·Mus musculus
- CrygbNop/Crygb+ [background:] Not Specified·MGI:2175807·Mus musculus
- Tg(Hsf4/EGFP)N7Spbh/0 [background:] C57BL/6-Tg(Hsf4/EGFP)N7Spbh·MGI:5810684·Mus musculus
- MipCat-Tohm/MipCat-Tohm [background:] involves: DDI·MGI:2657109·Mus musculus
- Crygsrncat/Crygsrncat [background:] Kunming·MGI:2181684·Mus musculus
- Cryba1Po1/Cryba1Po1 [background:] C3HeB/FeJ-Cryba1Po1·MGI:2175801·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
12,211
12,211 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
12,211 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
8,271 in the last 10 years · low confidence
Phrase hits: 0 · MeSH hits: 0
Who's working on it?
0
Distinct author names in 0 sampled papers.
Who's working on it?
No author names could be extracted from the sampled publications. Try the Europe PMC query in “How we counted this,” or contact an umbrella rare-disease organisation for researcher referrals.
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 1,246 trials are registered for cataract, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
1,246 interventional trials matched cataract, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: cataract
1,246
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07441616·NOT YET RECRUITING·Partial Range Of Field IOLs in DMEK-Enabled Procedures
Conditions: Cataract · Fuchs Endothelial Corneal Dystrophy·Matched via name phrase
- NCT07019896·RECRUITING·Minimal Vitrectomy Surgery for Epiretinal Membrane
Conditions: Epiretinal Membrane · Macular Edema (ME) · Nuclear Cataract·Matched via name phrase
- NCT05364983·NOT YET RECRUITING·Clinical Study to Evaluate the LensGen® Juvene® Intraocular Lens
Conditions: Cataract · Presbyopia·Matched via name phrase
- NCT07070492·NOT YET RECRUITING·Outcomes of Combined Cataract Surgery With Retinal Surgery for Visually Significant Epiretinal Membrane With Vivity Versus Monofocal Intraocular Lens
Conditions: Cataract and IOL Surgery · Epi-retinal Membrane·Matched via name phrase
- NCT07452770·RECRUITING·Stress Ball Use During Cataract Surgery: Effects on Pain, Fear and Satisfaction
Conditions: Pain · Fear · Stress Ball · Nursing·Matched via name phrase
- NCT07321756·RECRUITING·Evaluating Presbyopia-Correcting IOLs in Complex Cataract Cases With Anterior Segment Abnormalities
Conditions: Lens Diseases·Matched via name phrase
- NCT05157113·RECRUITING·Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
Conditions: Cataract · Surgery · Compliance, Patient · Compliance, Medication·Matched via name phrase
- NCT06874452·RECRUITING·An Extension Test of Whether to Use Oral Anti-anxiety Drugs (Alprazolam) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain Satisfaction
Conditions: Ophthalmology · Cataract Surgery Anesthesia · Oral Anxiolytic · Satisfaction Survey·Matched via name phrase
- NCT07556133·RECRUITING·Dexmedetomidine and Propofol for Sedation in Cataract Surgery.
Conditions: Sedation · Cataract · Hemodynamic · Hemodynamic Changes·Matched via name phrase
- NCT05980117·RECRUITING·Remimazolam for Cataract Surgery
Conditions: Cataract Surgery · Cognitive Impairment·Matched via name phrase
- NCT07294716·RECRUITING·Improving Visual Quality in Patients With Irregular Corneas Using Asymmetrical Toric Intraocular Lenses
Conditions: Irregular Astigmatism · Astigmatism · Cataract and IOL Surgery·Matched via name phrase
- NCT06922084·RECRUITING·A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
Conditions: Cataract·Matched via name phrase
- NCT06528509·NOT YET RECRUITING·AI-Enhanced Consent for Cataract Surgery
Conditions: Cataract·Matched via name phrase
- NCT05694858·RECRUITING·Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adults in Clinical Setting
Conditions: Glaucoma · Cataract · Ophthalmological Disorder·Matched via name phrase
- NCT06625749·RECRUITING·Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery
Conditions: Refractive Surgery · Refractive Error - Myopia·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Early onset non-syndromic cataract — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Early onset non-syndromic cataract") OR ("BFSP2" OR "BFSP2 syndrome" OR "BFSP2-related" OR "CRYBB3" OR "CRYBB3 syndrome" OR "CRYBB3-related" OR "EPHA2" OR "EPHA2 syndrome" OR "EPHA2-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Early onset non-syndromic cataract"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"cataract"
Query health: ok — strategies attempted: phrase; with hits: none
Parent literature probe: cataract (MONDO:0005129) — 197446 hits
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (12211) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T04:03:50.385Z
